Curran Matthew Simpson

1 Patent

• US116137392023

  Treatment of Mucopolysaccharidosis II with Recombinant Human Iduronate-2-sulfatase (IDS) Produced by Human Neural or Glial Cells

  REGENXBIO Inc.

  0 cites